Literature DB >> 30989826

RNA regulation of the antiviral protein 2'-5'-oligoadenylate synthetase.

Samantha L Schwartz1, Graeme L Conn1.   

Abstract

The innate immune system is a broad collection of critical intra- and extra-cellular processes that limit the infectivity of diverse pathogens. The 2'-5'-oligoadenylate synthetase (OAS) family of enzymes are important sensors of cytosolic double-stranded RNA (dsRNA) that play a critical role in limiting viral infection by activating the latent ribonuclease (RNase L) to halt viral replication and establish an antiviral state. Attesting to the importance of the OAS/RNase L pathway, diverse viruses have developed numerous distinct strategies to evade the effects of OAS activation. How OAS proteins are regulated by viral or cellular RNAs is not fully understood but several recent studies have provided important new insights into the molecular mechanisms of OAS activation by dsRNA. Other studies have revealed unanticipated features of RNA sequence and structure that strongly enhance activation of at least one OAS family member. While these discoveries represent important advances, they also underscore the fact that much remains to be learned about RNA-mediated regulation of the OAS/RNase L pathway. In particular, defining the full complement of RNA molecular signatures that activate OAS is essential to our understanding of how these proteins maximize their protective role against pathogens while still accurately discriminating host molecules to avoid inadvertent activation by cellular RNAs. A more complete knowledge of OAS regulation may also serve as a foundation for the development of novel antiviral therapeutic strategies and lead the way to a deeper understanding of currently unappreciated cellular functions of the OAS/RNase L pathway in the absence of infection. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications Translation > Translation Regulation.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  RNA structure; double-stranded RNA; innate immunity; oligoadenylate synthetase/ribonuclease L; translational regulation; virus

Mesh:

Substances:

Year:  2019        PMID: 30989826      PMCID: PMC6585406          DOI: 10.1002/wrna.1534

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  101 in total

1.  Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.

Authors:  Kwanbok Lee; Nawapol Kunkeaw; Sung Ho Jeon; Inhan Lee; Betty H Johnson; Gum-Yong Kang; Joo Young Bang; Hyung Soon Park; Chanvit Leelayuwat; Yong Sun Lee
Journal:  RNA       Date:  2011-04-25       Impact factor: 4.942

2.  Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells.

Authors:  S Besse; D Rebouillat; I Marie; F Puvion-Dutilleul; A G Hovanessian
Journal:  Exp Cell Res       Date:  1998-03-15       Impact factor: 3.905

3.  A human cellular noncoding RNA activates the antiviral protein 2'-5'-oligoadenylate synthetase 1.

Authors:  Brenda M Calderon; Graeme L Conn
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

Review 4.  Intracellular detection of viral nucleic acids.

Authors:  Konstantin M J Sparrer; Michaela U Gack
Journal:  Curr Opin Microbiol       Date:  2015-03-18       Impact factor: 7.934

5.  OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.

Authors:  L Leigh Field; Vagn Bonnevie-Nielsen; Flemming Pociot; Shao Lu; Thomas B Nielsen; Henning Beck-Nielsen
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

6.  Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection.

Authors:  Imtiaz Yakub; Kristy M Lillibridge; Ana Moran; Omar Y Gonzalez; John Belmont; Richard A Gibbs; David J Tweardy
Journal:  J Infect Dis       Date:  2005-10-12       Impact factor: 5.226

7.  2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancer.

Authors:  Sanjay Mandal; Fisseha Abebe; Jaideep Chaudhary
Journal:  Cancer       Date:  2011-06-02       Impact factor: 6.860

8.  Human noncoding RNA 886 (nc886) adopts two structurally distinct conformers that are functionally opposing regulators of PKR.

Authors:  Brenda M Calderon; Graeme L Conn
Journal:  RNA       Date:  2017-01-09       Impact factor: 4.942

9.  RNase L Cleavage Products Promote Switch from Autophagy to Apoptosis by Caspase-Mediated Cleavage of Beclin-1.

Authors:  Mohammad Adnan Siddiqui; Sushovita Mukherjee; Praveen Manivannan; Krishnamurthy Malathi
Journal:  Int J Mol Sci       Date:  2015-07-31       Impact factor: 5.923

10.  Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity.

Authors:  Hao Huang; Elton Zeqiraj; Beihua Dong; Babal Kant Jha; Nicole M Duffy; Stephen Orlicky; Neroshan Thevakumaran; Manisha Talukdar; Monica C Pillon; Derek F Ceccarelli; Leo C K Wan; Yu-Chi Juang; Daniel Y L Mao; Christina Gaughan; Margo A Brinton; Andrey A Perelygin; Igor Kourinov; Alba Guarné; Robert H Silverman; Frank Sicheri
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

View more
  19 in total

1.  Mature Rotavirus Particles Contain Equivalent Amounts of 7meGpppG-Capped and Noncapped Viral Positive-Sense RNAs.

Authors:  Joaquin Moreno-Contreras; Liliana Sánchez-Tacuba; Carlos F Arias; Susana López
Journal:  J Virol       Date:  2022-08-24       Impact factor: 6.549

Review 2.  The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2.

Authors:  Saba R Aliyari; Natalie Quanquin; Olivier Pernet; Shilei Zhang; Lulan Wang; Genhong Cheng
Journal:  Pathogens       Date:  2022-05-03

3.  Biological Characterization and Clinical Value of OAS Gene Family in Pancreatic Cancer.

Authors:  Li-Juan Gao; Jia-Lei Li; Rui-Rui Yang; Zhong-Mei He; Min Yan; Xia Cao; Ji-Min Cao
Journal:  Front Oncol       Date:  2022-06-03       Impact factor: 5.738

4.  Specific Recognition of the 5'-Untranslated Region of West Nile Virus Genome by Human Innate Immune System.

Authors:  Emmanuelle Bignon; Marco Marazzi; Tom Miclot; Giampaolo Barone; Antonio Monari
Journal:  Viruses       Date:  2022-06-13       Impact factor: 5.818

Review 5.  HEPN RNases - an emerging class of functionally distinct RNA processing and degradation enzymes.

Authors:  Monica C Pillon; Jacob Gordon; Meredith N Frazier; Robin E Stanley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-22       Impact factor: 8.250

Review 6.  MHC Class III RNA Binding Proteins and Immunity.

Authors:  Geraldine Schott; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2020-12-20       Impact factor: 4.652

7.  Inducible CRISPR activation screen for interferon-stimulated genes identifies OAS1 as a SARS-CoV-2 restriction factor.

Authors:  Oded Danziger; Roosheel S Patel; Emma J DeGrace; Mikaela R Rosen; Brad R Rosenberg
Journal:  PLoS Pathog       Date:  2022-04-14       Impact factor: 7.464

Review 8.  The Role of Immunogenetics in COVID-19.

Authors:  Fanny Pojero; Giuseppina Candore; Calogero Caruso; Danilo Di Bona; David A Groneberg; Mattia E Ligotti; Giulia Accardi; Anna Aiello
Journal:  Int J Mol Sci       Date:  2021-03-05       Impact factor: 5.923

9.  Inhibition of cGAS-Mediated Interferon Response Facilitates Transgene Expression.

Authors:  Yajuan Fu; Yijun Fang; Zhang Lin; Lei Yang; Liqun Zheng; Hao Hu; Tingting Yu; Baoting Huang; Suxing Chen; Hanze Wang; Shan Xu; Wei Bao; Qi Chen; Lijun Sun
Journal:  iScience       Date:  2020-03-31

10.  TMEM41B is a pan-flavivirus host factor.

Authors:  H-Heinrich Hoffmann; William M Schneider; Kathryn Rozen-Gagnon; Linde A Miles; Felix Schuster; Brandon Razooky; Eliana Jacobson; Xianfang Wu; Soon Yi; Charles M Rudin; Margaret R MacDonald; Laura K McMullan; John T Poirier; Charles M Rice
Journal:  bioRxiv       Date:  2020-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.